Nutex HealthNASDAQ: NUTX

HOUSTON , June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024.  The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306.

COMPANY EXPECTS TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID REQUIREMENT BEFORE JULY 22, 2024 HOUSTON , June 19, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16. On June 14, 2024, the Company received notice from the Nasdaq Stock Market LLC ("Nasdaq") that a Nasdaq Hearings Panel had granted the Company an exception until July 22, 2024 to effect a reverse stock split of its common stock once approved by its Board of Directors and the Company's stockholders.

HOUSTON , May 24, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced that it had had received a staff determination letter  on May21, 2024 from the Listing Qualifications Department  of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), the Company's Common Stock would be scheduled for delisting from The Nasdaq Capital Market and would be suspended for trading at the opening of business on May 30, 2024 unless the Company timely requests a hearing before an independent Nasdaq Hearings Panel (the "Panel") by May 28, 2024.  On May 23, 2024, the Company submitted a request for a hearing to appeal the Staff's delisting determination.

Nutex Health (NASDAQ: NUTX ) stock is dropping on Friday after the company announced plans for a reverse split of its shares. Nutex Health intends to enact a one-for-15 reverse stock split before markets open on April 10.

Nutex Health Inc. (NUTX) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.

Nutex now operates 20 micro-hospitals across eight states. The company has posted a loss for four consecutive quarters.

A company director bought 50,000 shares of Nutex on Thursday. The healthcare tech provider said it plans to expand by four or five hospitals this year.

HOUSTON , May 16, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that leadership is participating at the following investor conferences: RBC Global Healthcare Conference Date:  May 16, 2023Venue: InterContinental New York Barclay Hotel Benchmark Company Healthcare House Call Conference Date: May 23, 2023 Venue:  Virtual Management will be participating in one-on-one meetings at these events with investors.  The Company's presentation has been filed as an 8-K with the SEC.